Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons

    September 2025 in “ Dermatology and Therapy ”
    Stephano Cedirian, Monia Donati, Luca Rapparini, Francesca Pampaloni, M. La Plaça, Rossella Sgarzani, Luca Negosanti, Emanuel Raschi, Michela Starace
    Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are effective in treating type 2 diabetes and obesity, with additional benefits for dermatologic conditions like psoriasis and hidradenitis suppurativa due to their anti-inflammatory and immunomodulatory effects. However, they can cause cutaneous adverse reactions and pose challenges in aesthetic and reconstructive surgery, such as facial volume depletion and impaired wound healing due to rapid weight loss. Additionally, delayed gastric emptying from GLP-1 RAs necessitates careful perioperative management to mitigate risks like pulmonary aspiration. This review evaluates the benefits and risks of GLP-1 RAs for dermatologists and plastic surgeons.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 31 results

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 2 years ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Did UCLA Just Cure Baldness? Check this Out!

      in Research/Science  968 upvotes 1 year ago
      UCLA's PP405 shows promise in reactivating dormant hair follicles for hair loss treatment but is still in clinical trials. Minoxidil and finasteride remain common treatments until PP405 becomes available.

      community Will Pp405 be the Ozempic of bald Guys

      in Research/Science  102 upvotes 1 month ago
      PP405 is being discussed as a potential hair loss treatment, possibly more effective than minoxidil. There are concerns about its effectiveness and product contamination, but some users report early signs of hair regrowth.

      community He used Dutasteride for 20 years. Interview

      in Treatment  112 upvotes 1 year ago
      Dutasteride has been used for 20 years with some hair thickness improvement but no dramatic regrowth. The user also experimented with minoxidil, tretinoin, and peptides like BPC 157 for potential benefits in hair density and quality.

    Similar Research

    5 / 229 results